Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls.

Zhang M, Jabbari N, Satpathy M, Matyunina LV, Wang Y, McDonald LD, McDonald JF.

Cancer Lett. 2019 Sep 10;459:168-175. doi: 10.1016/j.canlet.2019.05.039. Epub 2019 Jun 1.

2.

Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.

Satpathy M, Wang L, Zielinski RJ, Qian W, Wang YA, Mohs AM, Kairdolf BA, Ji X, Capala J, Lipowska M, Nie S, Mao H, Yang L.

Theranostics. 2019 Jan 24;9(3):778-795. doi: 10.7150/thno.29964. eCollection 2019.

3.

Time-course analysis of microRNA-induced mesenchymal-to-epithelial transition underscores the complexity of the underlying molecular processes.

Lili LN, Huang AD, Zhang M, Wang L, McDonald LD, Matyunina LV, Satpathy M, McDonald JF.

Cancer Lett. 2018 Aug 1;428:184-191. doi: 10.1016/j.canlet.2018.05.001. Epub 2018 May 5.

4.

Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity.

Satpathy M, Mezencev R, Wang L, McDonald JF.

Sci Rep. 2016 Nov 7;6:36518. doi: 10.1038/srep36518.

5.

Optical imaging of ovarian cancer using HER-2 affibody conjugated nanoparticles.

Satpathy M, Zielinski R, Lyakhov I, Yang L.

Methods Mol Biol. 2015;1219:171-85. doi: 10.1007/978-1-4939-1661-0_13.

6.

HER-2/neu targeted delivery of a nanoprobe enables dual photoacoustic and fluorescence tomography of ovarian cancer.

Xi L, Satpathy M, Zhao Q, Qian W, Yang L, Jiang H.

Nanomedicine. 2014 Apr;10(3):669-77. doi: 10.1016/j.nano.2013.11.004. Epub 2013 Nov 19.

7.

Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors.

Satpathy M, Wang L, Zielinski R, Qian W, Lipowska M, Capala J, Lee GY, Xu H, Wang YA, Mao H, Yang L.

Small. 2014 Feb 12;10(3):544-55. doi: 10.1002/smll.201301593. Epub 2013 Aug 27.

8.

Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.

Lee GY, Qian WP, Wang L, Wang YA, Staley CA, Satpathy M, Nie S, Mao H, Yang L.

ACS Nano. 2013 Mar 26;7(3):2078-89. doi: 10.1021/nn3043463. Epub 2013 Mar 12.

9.

Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.

Shao M, Cao L, Shen C, Satpathy M, Chelladurai B, Bigsby RM, Nakshatri H, Matei D.

Cancer Res. 2009 Dec 15;69(24):9192-201. doi: 10.1158/0008-5472.CAN-09-1257.

10.

Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.

Satpathy M, Shao M, Emerson R, Donner DB, Matei D.

J Biol Chem. 2009 Jun 5;284(23):15390-9. doi: 10.1074/jbc.M808331200. Epub 2009 Mar 26.

11.

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.

Cao L, Petrusca DN, Satpathy M, Nakshatri H, Petrache I, Matei D.

Carcinogenesis. 2008 Oct;29(10):1893-900. doi: 10.1093/carcin/bgn158. Epub 2008 Jul 29.

12.

Forskolin induces myosin light chain dephosphorylation in bovine trabecular meshwork cells.

Ramachandran C, Satpathy M, Mehta D, Srinivas SP.

Curr Eye Res. 2008 Feb;33(2):169-76. doi: 10.1080/02713680701837067.

PMID:
18293188
13.

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.

Satpathy M, Cao L, Pincheira R, Emerson R, Bigsby R, Nakshatri H, Matei D.

Cancer Res. 2007 Aug 1;67(15):7194-202.

14.

Histamine-induced myosin light chain phosphorylation breaks down the barrier integrity of cultured corneal epithelial cells.

Guo Y, Ramachandran C, Satpathy M, Srinivas SP.

Pharm Res. 2007 Oct;24(10):1824-33. Epub 2007 May 4.

PMID:
17479229
15.

Benzalkonium chloride induces dephosphorylation of Myosin light chain in cultured corneal epithelial cells.

Guo Y, Satpathy M, Wilson G, Srinivas SP.

Invest Ophthalmol Vis Sci. 2007 May;48(5):2001-8.

PMID:
17460253
16.

The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells.

Matei D, Satpathy M, Cao L, Lai YC, Nakshatri H, Donner DB.

J Biol Chem. 2007 Jan 5;282(1):445-53. Epub 2006 Nov 1.

17.

Histamine-induced phosphorylation of the regulatory light chain of myosin II disrupts the barrier integrity of corneal endothelial cells.

Srinivas SP, Satpathy M, Guo Y, Anandan V.

Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4011-8.

PMID:
16936117
18.

Evidence of two forms of poly(A) polymerase in germinated wheat embryos and their regulation by a novel protein kinase.

Sharma N, Dey M, Satpathy M, Sachar RC.

Biochem Biophys Res Commun. 2002 Apr 26;293(1):403-11.

PMID:
12054614

Supplemental Content

Loading ...
Support Center